Schistosomiasis, sometimes called bilharzia or snail fever, remains one of the world’s most burdensome parasitic diseases. The worms responsible, Schistosoma mansoni and Schistosoma haematobium among them, spend part of their life cycle in freshwater snails and emerge as infectious larvae that penetrate human skin during contact with contaminated water. Adult worms then settle in the blood vessels around the intestines or the bladder, where female worms release thousands of eggs daily. S. mansoni eggs are shed in stool, while S. haematobium eggs exit in urine, and it is the detection of these eggs in laboratory examinations that reveals an active infection. Chronic disease can damage the liver, intestines, bladder, and kidneys, and in children it is associated with anemia and impaired growth and cognition.

Praziquantel, administered as a single oral dose of 40 milligrams per kilogram of body weight, is the backbone of global schistosomiasis control. Mass drug administration campaigns deliver the drug to entire at-risk communities, often school-aged children, on an annual or biannual schedule. Yet the drug has known limitations: it is highly effective against adult worms but does not act on immature stages, and cure rates vary widely between settings, parasite species, and individual patients. Understanding why those rates vary, and what factors predict treatment failure or rapid reinfection, is essential for programs deciding how often to treat and whom to prioritize.

The new study addressed this question in a setting where both major species coexist, a situation common across much of sub-Saharan Africa but underexplored in treatment trials. The researchers, led by Joule Ntwan Madinga and colleagues working with Congolese and Belgian institutions, randomly selected 388 residents of a village co-endemic for S. mansoni and S. haematobium. Rather than a single before-and-after assessment, they screened every participant every three weeks for nine consecutive weeks, using Kato-Katz thick smear examinations of stool to detect and quantify S. mansoni eggs and urine filtration to detect S. haematobium eggs. Anyone found positive at a visit was treated on the spot with praziquantel at the standard 40 milligrams per kilogram dose.

The baseline picture confirmed how intense transmission is in the village. Just over 60 percent of participants carried S. mansoni, and a nearly identical proportion carried S. haematobium, with 36.6 percent infected with both species simultaneously. More striking were the worm burdens implied by egg counts. People with mixed infections carried far heavier loads than those with single infections: S. mansoni egg counts averaged 200.7 eggs per gram of stool in co-infected individuals versus 70 in those infected with S. mansoni alone, and S. haematobium counts averaged 29 eggs per 10 milliliters of urine versus 9.6. Both differences were highly statistically significant. Co-infection, in other words, is not merely the sum of two independent infections but a marker of substantially greater exposure or susceptibility.

When the researchers examined treatment outcomes, the two species behaved very differently. A single round of praziquantel cured 94.6 percent of S. mansoni infections, with an egg reduction rate of 96.5 percent, meaning that among those not cured, egg output collapsed to a small fraction of pretreatment levels. S. haematobium proved considerably more stubborn: only 62.7 percent of infections were cured by one treatment, although egg reduction still reached 97.5 percent. After three rounds of treatment spaced across the nine-week follow-up, the cumulative cure rate for S. mansoni rose to 93.7 percent, while S. haematobium reached only 75 percent, with cumulative egg reduction rates of 97.5 and 95.6 percent respectively. The pattern suggests that repeated dosing closes much of the gap for intestinal schistosomiasis but leaves urinary schistosomiasis persisting in a quarter of patients.

Co-infection status emerged as a key modifier of these outcomes. Treatment efficacy was significantly higher in people with single infections than in those with mixed infections across every measure the team calculated, including cure rate, egg reduction rate, and their cumulative counterparts. Single infections achieved a cure rate of 76.7 percent compared with 58 percent for mixed infections, a difference with a p-value of 0.01. The authors note that this effect was driven primarily by S. haematobium, the species that already showed weaker cure rates on its own. Age mattered as well: adults and older participants cleared their infections more readily than children under 16, a finding consistent with the possibility that younger children in high-transmission settings carry infections that include immature worms less susceptible to the drug, or that their heavier and more recent exposure leaves them with larger worm populations at treatment.

Perhaps the most reassuring result concerns what happened after treatment. The team tracked reinfection over the follow-up period and found no significant association between a person’s pretreatment co-infection status and their likelihood of becoming reinfected. In other words, carrying both species before treatment makes the initial cure harder to achieve, but it does not appear to make a cured person more vulnerable to picking up new worms afterward. Reinfection in such settings is governed largely by ongoing exposure to contaminated water, which affects the community broadly regardless of an individual’s prior infection history. This distinction matters because it separates a pharmacological problem, which repeated or adjusted dosing might address, from an environmental one, which requires safe water, sanitation, and snail control.

The authors suggest that these findings could help tailor control activities in co-endemic areas. Where both species overlap, programs may need to anticipate lower cure rates, particularly for S. haematobium and for co-infected individuals, and consider more frequent treatment rounds to achieve cumulative cure. The high egg reduction rates even among uncured patients offer some comfort: praziquantel suppresses egg output dramatically, which likely reduces both disease progression and transmission even when worms survive. But the persistence of a quarter of S. haematobium infections after three treatments underscores that a one-size-fits-all annual dose may be insufficient in the hottest transmission foci.

The study also carries implications for how treatment success is measured. Programs typically evaluate mass drug administration using single-dose cure rates, which this research shows can substantially understate the drug’s cumulative effect, especially for S. mansoni, whose cure rate climbed from 62.7 percent after one round to 93.7 percent after three. Conversely, the persistent shortfall for S. haematobium suggests that species-specific monitoring is warranted in mixed-endemic villages. As global goals shift from controlling schistosomiasis toward eliminating it as a public health problem, understanding the fine-grained dynamics of mixed infections, drug efficacy, and reinfection in places like this Congolese village will be central to designing strategies that finally bend the transmission curve.

Subject of Research: Praziquantel efficacy and reinfection dynamics in mixed Schistosoma mansoni and Schistosoma haematobium infections in the Democratic Republic of Congo

Article Title: Impact of praziquantel treatment and early reinfection patterns in a mixed Schistosoma mansoni and Schistosoma haematobium infection focus in the Democratic Republic of Congo

Article References: Madinga, J. N., Roucher, C., Linsuke, S., Baloji, S., Hermy, M., Lutumba, P., & Polman, K. (2026). Impact of praziquantel treatment and early reinfection patterns in a mixed Schistosoma mansoni and Schistosoma haematobium infection focus in the Democratic Republic of Congo. PLOS Neglected Tropical Diseases, 20(10), e0014764. https://doi.org/10.1371/journal.pntd.0014764

Image Credits: AI Generated

DOI: 10.1371/journal.pntd.0014764

Keywords: schistosomiasis, praziquantel, Schistosoma mansoni, Schistosoma haematobium, co-infection, Democratic Republic of Congo, cure rate, reinfection, neglected tropical diseases, mass drug administration, Kato-Katz, urine filtration

Schistosomiasis, also known as bilharzia, is caused by trematode flatworms of the genus Schistosoma, whose eggs are shed in the urine or feces of infected people. When those eggs reach freshwater, they hatch into free-swimming miracidia that must find and penetrate a suitable snail host within hours to survive. Inside Biomphalaria snails, Schistosoma mansoni larvae multiply asexually before emerging as infectious cercariae; inside Bulinus snails, the same role is played by Schistosoma haematobium, the species responsible for urogenital schistosomiasis. These cercariae then seek out human hosts in the water, burrowing through the skin and maturing into adult worms that can live for years, producing thousands of eggs daily. Breaking this cycle at the snail stage has long been recognized as a critical lever for control, yet reliable, up-to-date data on how many snails actually carry infection has been scattered across dozens of small field studies.

To close that gap, a team of researchers led by Sisay Desale and Zewudu Mulatie of Wollo University in Ethiopia, working with colleagues in Ethiopia and Iran, conducted a review following the PRISMA 2020 reporting guidelines. The team searched five electronic databases for studies published between January 2020 and December 2025, a window that refers strictly to publication dates; the underlying snail sampling periods of the included studies stretched much further back, from 2009 through 2025. After screening, seventeen studies qualified for inclusion, contributing twenty-seven separate datasets. The researchers pooled study-level proportions using the Freeman-Tukey double-arcsine transformation to stabilize variance in proportions near zero or one, combined with a DerSimonian-Laird random-effects model implemented in Stata 17, and calculated exact binomial confidence intervals for individual estimates.

The headline number from the analysis is an overall pooled prevalence of 8.88 percent, with a 95 percent confidence interval running from 5.61 to 12.14 percent. But the authors are careful, and unusually candid, about what that figure does and does not mean. The statistical heterogeneity across datasets was extreme, with Higgins’ inconsistency index, I², reaching 100 percent and a p-value below 0.001. Under such conditions, the DerSimonian-Laird weighting scheme effectively assigns nearly equal weight to every dataset regardless of sample size, meaning the pooled estimate approximates the unweighted average of the twenty-seven dataset proportions rather than a true sample-weighted regional prevalence. The crude prevalence across all snails examined was considerably lower: 1,615 infected snails out of 72,473 examined, or 2.23 percent. Because of this discrepancy, the authors emphasize subgroup estimates over the overall pooled figure, a methodological caution that other meta-analysts would do well to emulate.

The subgroup findings are where the biological story emerges. Infection prevalence was significantly higher in Biomphalaria snails, at 13.44 percent, than in Bulinus snails, at 2.24 percent, and higher for Schistosoma mansoni than for Schistosoma haematobium, with p-values below 0.001 for both comparisons. This asymmetry matters for control planning: intestinal schistosomiasis caused by S. mansoni appears to be sustained by a substantially larger environmental reservoir than the urogenital form carried by Bulinus species. Geography also mattered. Ethiopia reported the highest pooled prevalence of any country in the analysis, at 16.79 percent, a finding consistent with the country’s extensive freshwater habitats and the intensity of schistosomiasis transmission documented in human surveys there. Estimates also varied by study design, diagnostic method, and publication year, though the authors stress that these exploratory meta-regression findings should be treated as hypothesis-generating rather than definitive, because residual heterogeneity remained at I² equal to 100 percent in every model they fitted.

One of the most intriguing results concerns diagnostic methodology, and it runs counter to conventional expectations. Cercarial shedding, the traditional method in which snails are induced to release parasites under light or heat, yielded a pooled prevalence of 9.98 percent, while polymerase chain reaction, or PCR, alone yielded 10.83 percent. Most strikingly, studies that combined shedding with PCR reported a pooled prevalence of only 3.35 percent. In the meta-regression, PCR alone did not differ significantly from shedding alone. Molecular methods are generally assumed to detect more infections than shedding, since they can identify pre-patent infections in which parasites are present but not yet producing cercariae. The fact that the combined-method stratum produced the lowest estimate suggests that methodological differences here are entangled with other variables rather than reflecting a clean diagnostic comparison.

The authors themselves flag exactly why that interpretation is hazardous. The PCR-alone stratum comprised four datasets drawn from a single Ugandan study of snails collected in 2009 and 2010, meaning the diagnostic method is fully confounded with country, host genus, and sampling period. In other words, the apparent similarity between PCR and shedding estimates, and the low figure for combined methods, cannot be attributed to the diagnostic techniques themselves; they may simply reflect the particular snails, places, and years those datasets happened to cover. This is a textbook illustration of why meta-regression on heterogeneous observational data must be read with care, and the study’s transparency about these limitations strengthens rather than weakens its conclusions.

What can be said with confidence is that infected intermediate host snails, especially Biomphalaria species harboring S. mansoni, were documented across the East African sites covered by the included studies, and that the published evidence base describes an uneven and temporally fragmented picture rather than a uniform snapshot of current transmission. Sampling periods span sixteen years and are distributed unevenly across countries, host genera, and diagnostic methods, so the estimates describe what has been published rather than what is happening in every water body today. That distinction is crucial for policymakers: a pooled prevalence drawn partly from snails collected in 2009 cannot be read as the 2025 infection pressure in a given village pond, but it does demonstrate that the environmental reservoir of infection has been continuously present across the region throughout the period in which mass drug administration has been scaled up.

The study’s practical recommendations follow directly from this logic. The authors call for coordinated, site-specific strategies that combine mass medicine delivery with targeted snail removal, molecular xenomonitoring, environmental management, and sensitive snail surveillance. Molecular xenomonitoring, in which snail pools are tested for parasite DNA using PCR or loop-mediated isothermal amplification, offers a way to map transmission intensity at fine spatial resolution without relying on the seasonal and species-limited window that cercarial shedding provides. Paired with mollusciciding and habitat modification, such surveillance could identify the specific water bodies where infected Biomphalaria populations persist and direct interventions where they will break transmission most effectively. As the WHO’s 2030 elimination deadline approaches, this analysis makes clear that the final mile of schistosomiasis control will be won or lost not only in clinics and classrooms where drugs are distributed, but in the shallow, warm freshwater habitats where snails and parasites continue their ancient partnership, largely out of sight and, until now, largely out of reliable statistical view.

Subject of Research: Prevalence of Schistosoma mansoni and S. haematobium infection in freshwater snail intermediate hosts in East Africa

Article Title: Prevalence of Schistosoma mansoni and S. haematobium in snail intermediate hosts in East Africa: a systematic review and meta-analysis of studies published between 2020 and 2025

Article References: Desale, S., Siyadatpanah, A., Eshetu, B., Aseme, A. H., Sebsibe, S., Erkihun, Y., Kassa, Y., Gessese, T., Alebachew, M., Achame, M. S., Feyisa, M. S., & Mulatie, Z. (2026). Prevalence of Schistosoma mansoni and S. haematobium in snail intermediate hosts in East Africa: a systematic review and meta-analysis of studies published between 2020 and 2025. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14535-5

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14535-5

Keywords: schistosomiasis, Schistosoma mansoni, Schistosoma haematobium, intermediate host snails, Biomphalaria, Bulinus, East Africa, meta-analysis, molecular xenomonitoring, neglected tropical diseases, WHO 2030 roadmap, Ethiopia

Integrins are heterodimeric adhesion receptors composed of an alpha and a beta chain, and they sit embedded in cell membranes across virtually all metazoan life. Their job is deceptively simple but biologically profound: they anchor cells to the extracellular matrix, transmit mechanical forces, and relay chemical signals from outside the cell to the interior. In humans, integrins are implicated in everything from wound healing to cancer metastasis, and they have become prized pharmaceutical targets. In parasitic helminths, however, integrin homologues have been identified at the sequence level for years, yet their three-dimensional organization and ligand-binding behavior remained largely uncharted territory. The new study set out to close that gap using an integrative computational pipeline rather than laboratory experiments alone.

The researchers began with comparative sequence analysis across medically important Schistosoma species, searching for conserved integrin genes in the genomes of the parasites. Their screen revealed a striking asymmetry. On the beta side, a single highly conserved orthologue, which they named Smβ1, was present and well preserved across species, suggesting that it performs an essential function that evolution has been reluctant to alter. On the alpha side, the picture was more complicated: four divergent alpha-integrin subunits were identified, each carrying distinctive sequence features that hinted at different evolutionary histories and potentially different binding partners. This combination of one conserved beta chain and several variable alpha chains mirrors the architecture of integrin systems in other organisms, where the beta subunit provides the core ligand-binding machinery and the alpha subunit tunes its specificity.

To move from sequences to structures, the team deployed three independent protein-structure prediction engines: AlphaFold3, RoseTTAFold and trRosetta. Convergent predictions from these tools showed that the betaI-containing region of Smβ1 retains the characteristic integrin fold that has been described in exquisite detail for human receptors. Critically, the model preserved the three canonical metal-coordination sites that define integrin ligand recognition: the metal-ion-dependent adhesion site, known as MIDAS, which directly coordinates the acidic residue of incoming ligands; the adjacent ADMIDAS site, which allosterically regulates the receptor’s activation state; and the synergistic metal-binding site, or SyMBS, which helps stabilize the ligand-bound conformation. The retention of these features in a parasite receptor is significant because it suggests that the fundamental chemistry of integrin-ligand engagement, dependent on metal ions bridging receptor and ligand, has been conserved across hundreds of millions of years of evolution separating flatworms from vertebrates.

With individual subunit structures in hand, the next challenge was determining which alpha chain pairs with Smβ1. Integrin function depends entirely on the correct heterodimer assembly, and predicting which of the four candidate alpha subunits forms a stable, functional complex with the beta chain is a problem that sequence similarity alone cannot solve. The researchers therefore constructed an integrated structural benchmarking framework that scored each candidate assembly across multiple independent dimensions: conservation of the overall fold, stereochemical and backbone quality of the predicted model, VoroMQA-based assessment of Voronoi packing density, the architecture of the alpha-beta interface itself, the buried surface area at the interface, and separate interface-context analyses designed to catch artifacts that single metrics might miss.

When the scores were tallied, one pairing stood out. Smα1 in combination with Smβ1 was ranked as the leading heterodimer candidate, while Smα3 paired with Smβ1 remained a structurally plausible alternative that could not be excluded. This ranking mattered because the identity of the alpha subunit shapes the geometry of the ligand-binding pocket that forms at the interface between the two chains. The team then subjected both candidate assemblies to ligand-challenge modelling, docking RGD-containing peptides into the predicted binding sites and comparing the resulting interaction geometries against a human α5β1 integrin benchmark whose RGD-bound structure is experimentally established.

The results were revealing. Smα1/Smβ1 more readily reproduced the coupled interaction pattern seen in the human benchmark, in which the arginine residue of the RGD motif anchors to a defined pocket on the alpha subunit while the aspartate residue coordinates the MIDAS metal ion on the beta subunit. Smα3/Smβ1, by contrast, was less consistent in reproducing this canonical geometry. Across expanded ensembles of ligand structures, canonical and cyclic RGD-containing peptides preferentially adopted RGD-like interaction geometries with the receptor, whereas an RGE mutant peptide, in which the aspartate is replaced by glutamate, and various non-RGD control peptides showed reduced or absent canonical interaction features. This specificity pattern is exactly what one would expect from a genuine RGD-recognizing integrin, since the RGE substitution is a classic experimental control that abolishes integrin binding in well-characterized systems.

Molecular dynamics simulations provided the temporal dimension that static docking cannot capture. In trajectories running 100 and 200 nanoseconds, the canonical RGD peptide remained within a comparatively restricted conformational regime associated with the receptor, suggesting a stable engagement, while the RGE mutant underwent greater displacement and induced more structural mobility in the contact site. Complementary MM/GBSA energetic analysis computed over the 200-nanosecond trajectory frames further supported more favourable energetic compatibility for RGD than for RGE. Together, these dynamic and energetic measures reinforce the picture painted by the docking experiments: the Smα1/Smβ1 complex behaves, under modelled conditions, like a receptor that genuinely prefers RGD ligands over near-identical decoys.

Beyond ligand binding, the study ventured into signaling territory with an exploratory network analysis using the STRING database. This placed Smβ1 within a predicted adhesome-like network that includes the integrin-linked kinase, or ILK, together with its PINCH and Parvin partners and kinase-associated components. In animal cells, the ILK-PINCH-Parvin complex is a central scaffold of the integrin adhesion complex, coupling receptors at the membrane to the actin cytoskeleton and to signaling pathways. Finding a predicted network of this composition around a schistosome beta integrin raises the possibility that the parasite uses signaling machinery broadly analogous to that of its host, which carries implications for how the worm adheres to and navigates host tissues during its complex life cycle.

The authors are careful to frame their conclusions as hypothesis-generating rather than definitive. Every result in the study derives from computational prediction and simulation, and the models, however sophisticated, remain subject to experimental validation. The paper explicitly presents its findings as experimentally testable hypotheses concerning alpha-beta pairing, metal-dependent ligand recognition and integrin-associated signaling in schistosomes. Still, the implications are considerable. If Smα1/Smβ1 is confirmed as a functional RGD-recognizing receptor, it would open a new window on how S. mansoni interacts with host extracellular matrix during infection, and it would offer a structurally characterized parasite-specific target whose human counterparts are already druggable, potentially accelerating the search for much-needed new therapies against a disease for which treatment still relies almost entirely on a single drug, praziquantel.

Subject of Research: Structural and ligand-binding characterization of Schistosoma mansoni integrin receptors

Article Title: Computational structural analysis of Schistosoma integrins supports Smα1/Smβ1 as an RGD-compatible receptor candidate

Article References: Adu, E. A., Owoloye, A., Shakela, N., Aziz, R. N., Boakye, A. O., Acheampong, E., Nyarko, E. N. Y., Adu-Amoah, L., Afum-Adjei Awuah, A., Amuasi, J. H., & Obirikorang, C. (2026). Computational structural analysis of Schistosoma integrins supports Smα1/Smβ1 as an RGD-compatible receptor candidate. BMC Genomics. https://doi.org/10.1186/s12864-026-13429-9

Image Credits: AI Generated

DOI: 10.1186/s12864-026-13429-9

Keywords: Schistosoma mansoni, schistosomiasis, integrins, Smβ1, Smα1, RGD motif, AlphaFold3, molecular dynamics, MIDAS, protein-ligand interactions, host-parasite interactions, structural genomics

The numbers are striking. Using the Kato-Katz technique, the standard coproscopic method recommended by the World Health Organization, researchers found a positivity rate of 23.68 percent among 266 residents who provided stool samples. When the team added the Hoffman, Pons and Janer sedimentation technique, six additional infections emerged. Crucially, they then applied real-time polymerase chain reaction to a subset of samples that had tested negative by both microscopic methods, and nearly 16.5 percent of those came back positive for parasite DNA. That molecular layer pushed the overall estimated prevalence to 28.94 percent, a figure the authors caution is likely still an underestimate, because qPCR was not applied to every negative sample and its greater sensitivity relative to parasitological techniques is well established.

This diagnostic gap matters far beyond academic precision. Under Brazilian Ministry of Health guidelines, the recommended response to schistosomiasis depends directly on the measured local positivity rate. In areas with rates between 15 and 25 percent, all positive cases and their household contacts should be treated with praziquantel. Above 25 percent, the guidance escalates to treating entire communities and prioritizing those areas for intensified control. A neighborhood that crosses that threshold on paper therefore triggers a fundamentally different public health strategy than one that appears quiet because insensitive tests missed low-burden infections. The Kato-Katz method, while practical and inexpensive, is known to perform poorly in individuals carrying few eggs, precisely the profile that dominates in low-transmission settings where control programs believe they are winning.

The study’s clinical findings add urgency. Of 55 infected residents who underwent upper abdominal ultrasound, 31 showed periportal fibrosis, the scarring around the liver’s portal veins that develops as the immune system walls off parasite eggs deposited in hepatic tissue. Fibrosis graded by the Niamey protocol ranged from peripheral ring echoes to advanced patterns. Consistent with the disease’s pathophysiology, individuals with fibrosis were significantly older, with a mean age of about 41 years compared with 21 among infected people without fibrosis, and they carried heavier parasite loads, averaging around 330 eggs per gram of stool. Fibrosis was also far more common in males, who made up roughly three quarters of the fibrosis group, echoing sex-related patterns reported across schistosomiasis research.

Perhaps most telling was the state of the portal vein. Infected residents with periportal fibrosis had a significantly larger portal vein diameter than those without, a measurement associated with progressing disease severity and, in advanced hepatosplenic cases, with the risk of life-threatening esophageal variceal bleeding. In this community-based sample the diameters remained within normal reference limits, and the researchers found no significant differences in spleen size or liver lobe measurements between groups, likely because only one participant showed the most advanced fibrosis pattern. That scarcity of severe disease is itself informative: it captures the pathology at a compensated, earlier stage, before the decompensated forms that fill referral hospitals, and it underlines why population-based surveys rather than hospital records are essential for understanding where transmission is heading.

One result stood out as a warning about early exposure. Although hepatic fibrosis typically requires years of chronic infection, and the relationship between age and fibrosis is generally treated as roughly linear, the team documented children and adolescents under 18 who already displayed pattern C peripheral fibrosis. The questionnaire data explain why. Residents described routine, involuntary contact with floodwater: roughly 98 percent of both infected and uninfected participants reported water accumulating on their streets, and almost no one had a practical means of avoiding exposure. In Novo Horizonte, infection risk is not tied to occupational fishing or farming but to simply walking through inundated streets during the rainy season, a hallmark of urban schistosomiasis.

The socioenvironmental picture is bleak in ways that map directly onto transmission. Fewer than 11 percent of infected residents lived on paved streets. About three quarters reported open septic tanks leaking sewage onto their roads, and more than 95 percent described standing water and flooding near their homes. Most infected individuals had lived in the area for at least five years, and duration of residence was one of the few socioenvironmental factors showing a statistically significant association with infection. Nearby water bodies harbor the Biomphalaria snails that serve as intermediate hosts, releasing the cercariae that penetrate human skin in a matter of minutes. In such an environment, every heavy rainfall converts streets into transmission sites.

History shows how hard this cycle is to break. An epidemiological assessment from 2011 recorded a 15.7 percent positivity rate in Novo Horizonte, which fell after collective treatment with praziquantel. More than two decades later, the parasite is back at roughly twice that level, demonstrating that mass drug administration alone, without durable sanitation infrastructure, produces only temporary suppression. Notably, among residents who tested negative by all three diagnostic methods, a full third nonetheless showed periportal fibrosis on ultrasound. The researchers suggest many were treated in earlier campaigns for infections that were never formally diagnosed, leaving behind fibrotic scars from cleared or subclinical infections, a hidden reservoir of morbidity that standard surveillance cannot see.

The broader Brazilian context makes these findings more consequential. National control program activity has been declining, and Pernambuco illustrates the trend: in 2024, of 240,436 coproscopic examinations scheduled across endemic municipalities, fewer than 43 percent were completed. Jaboatão dos Guararapes reached only about 30 percent of its scheduled exams, yielding an official municipal positivity of 3.2 percent, which qualifies it as low endemicity even as this study documents a moderately positive hotspot within its borders. Meanwhile the state recorded 1,528 deaths from schistosomiasis between 2015 and 2024, including 111 in the final year, and it carries the country’s highest hospitalization rates for the disease. Where screening coverage falls, deaths rise, and low official positivity rates may simply reflect too few tests rather than genuinely low transmission.

The study team, led by researchers at the Federal University of Pernambuco and the Oswaldo Cruz Foundation’s Aggeu Magalhães Institute, argues that frequent parasitological surveys, strengthened active case finding, and adoption of more sensitive molecular diagnostics are needed to interrupt transmission before severe hepatic disease takes hold. All infected participants received their results and referrals for praziquantel treatment under Brazilian program guidelines, and all participants or their guardians provided written informed consent, with ethical approval from the university’s research committee. The researchers also acknowledge limitations: younger residents were less likely to submit stool samples, and infrastructure constraints meant not every negative sample could undergo qPCR or ultrasound. Even so, the message from Novo Horizonte is difficult to ignore. In Brazil’s urbanizing coastal Northeast, a neglected tropical disease is quietly rewriting the maps that guide its control, and the communities most exposed to flooded, unsanitized streets are paying the price while official statistics lag behind the worms.

Subject of Research: Urban transmission and clinical burden of Schistosoma mansoni infection in Pernambuco, Brazil

Article Title: Epidemiological and Clinical-Laboratorial Profile of Schistosomiasis in an Endemic Urban Area in Pernambuco, Brazil

Article References: da Silva Pereira, M. E., Júnior, W. L. B., da Silva Fernandes, D. L. R., Domingues, A. L. C., de Lorena, V. M. B., & de Souza Gomes, E. C. (2026). Epidemiological and Clinical-Laboratorial Profile of Schistosomiasis in an Endemic Urban Area in Pernambuco, Brazil. Acta Parasitologica, 71(5), Article 206. https://doi.org/10.1007/s11686-026-01384-0

Image Credits: AI Generated

DOI: 10.1007/s11686-026-01384-0

Keywords: schistosomiasis, Schistosoma mansoni, neglected tropical diseases, Brazil, urban transmission, Pernambuco, periportal fibrosis, Kato-Katz, qPCR diagnosis, ultrasound, public health, praziquantel